Related references
Note: Only part of the references are listed.A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
John F. Deeken et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Recent advances in the study of immunodeficiency and DNA damage response
Tomohiro Morio
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications
Camille Roussel et al.
JOURNAL OF TRAVEL MEDICINE (2017)
MOLECULAR BIOLOGY The long and short of a DNA-damage response
Antonio Conconi et al.
NATURE (2017)
The anticancer activity of the antimalarial artesunate
Thomas Efferth
BIOCHEMICAL PHARMACOLOGY (2017)
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer
Maddalena Barba et al.
BMC CANCER (2017)
Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives
Archana Bhaw-Luximon et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
The DNA damage-induced cell death response: a roadmap to kill cancer cells
Sonja Matt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature
Simon B. Zeichner et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy
Gwenola Manic et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
Understanding Drug Resistance in Breast Cancer with Mathematical Oncology
Terisse Brocato et al.
CURRENT BREAST CANCER REPORTS (2014)
Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo
Xiang Zhou et al.
ANTI-CANCER DRUGS (2013)
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Martin Michaelis et al.
BIOCHEMICAL PHARMACOLOGY (2010)
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases
Suhail Ahmed Kabeer Rasheed et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Functional role of ATM in the cellular response to DNA damage
Ming Liu et al.
Frontiers of Chemical Science and Engineering (2010)
Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism
Yu-Min Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Share Paper
